DekaBank Deutsche Girozentrale - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,091
+2.6%
42,617
+6.5%
0.00%
+50.0%
Q2 2023$1,063
-99.7%
40,000
+53.3%
0.00%
+100.0%
Q2 2022$402,000
-44.1%
26,1000.0%0.00%
-50.0%
Q1 2022$719,000
-21.8%
26,100
+10.1%
0.00%0.0%
Q4 2021$920,000
-14.8%
23,700
+2.6%
0.00%
-33.3%
Q3 2021$1,080,000
+285.7%
23,100
+185.2%
0.00%
+200.0%
Q2 2021$280,000
-10.8%
8,1000.0%0.00%0.0%
Q1 2021$314,000
-8.5%
8,1000.0%0.00%0.0%
Q4 2020$343,0008,1000.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders